7 Results for "

Androgen receptor-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Androgen receptor-IN-3" in MCE Product Catalog:

Cat. No.: HY-131953
CAS No.: 926228-58-2
Target:  

Androgen Receptor

Research Areas:  

Cancer

Androgen receptor-IN-3 (Compound 22) is an androgen receptor inhibitor. Androgen receptor-IN-3 inhibits AR-driven transcriptional activity in LNCaP cells, with an IC50 of 5.04 μM .
loading...
    loading...
Cat. No.: HY-174244
CAS No.: 3082852-63-6
Research Areas:  

Cancer

3βHSD1-IN-1 (Compound 46) is a 3β-hydroxysteroid dehydrogenase 1 (3βHSD1) inhibitor with an IC50 of 55 nM. 3βHSD1-IN-1 can effectively inhibit androgen receptor activity. 3βHSD1-IN-1 can be used in the research of diseases such as prostate cancer .
loading...
    loading...
Cat. No.: HY-146026
CAS No.: 353484-46-5
Target:  

Androgen Receptor

Research Areas:  

Cancer

Androgen receptor antagonist 3 (Compound C18) is an androgen receptor (AR) antagonist with an IC50 of 2.4 μM. Androgen receptor antagonist 3 shows anticancer activities .
loading...
    loading...
Cat. No.: HY-171049
CAS No.: 1018971-95-3
Target:  

Androgen Receptor

Research Areas:  

Cardiovascular Disease

Androgen receptor modulator 3 is a selective modulator for androgen receptor that can be used for research of sarcopenia .
loading...
    loading...
Cat. No.: HY-N13475
CAS No.: 60760-95-4
(3R,3′R)-Astaxanthin is an androgen receptor binder. (3R,3′R)-Astaxanthin can be used in the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-179476
CAS No.: 847232-54-6
3-Oxochol-5-en-24-oic acid is a rare bile acid produced by the intestinal microbiota. 3-Oxochol-5-en-24-oic acid is a potent antagonist of the human androgen receptor (hAR), with an IC50 of 119.4 nM. 3-Oxochol-5-en-24-oic acid has no significant agonistic or antagonistic effects on estrogen receptors (ER) or glucocorticoid receptors (GR). 3-Oxochol-5-en-24-oic acid effectively inhibits the growth of prostate cancer cells. In animal models, it enhances the efficacy of anti-PD-1 therapy by regulating the differentiation of CD8 + T cells. 3-Oxochol-5-en-24-oic acid can be used for research on regulating host immunity and anti-tumor studies .
loading...
    loading...
Cat. No.: HY-W657887
CAS No.: 154866-92-9
GSK-3β/G9a-IN-1 (Compound T2) is an orally active, selective, blood-brain-barrier permeable, competitive G9a (substrate-competitive, IC50: 1.1 μM) and GSK-3β (ATP competitive, IC50: 0.8 μM) inhibitor. GSK-3β/G9a-IN-1 is a potent H3K9me2 inhibitor that reshapes chromatin landscape. GSK-3β/G9a-IN-1 lowers tau phosphorylation, reduces aggregation. GSK-3β/G9a-IN-1 displays inhibition toward glucocorticoid receptor, androgen receptor, and alpha-2A adrenergic receptor. GSK-3β/G9a-IN-1 also upregulates SAGA complex members such as Eny2 and Sgf29. GSK-3β/G9a-IN-1 markedly improves memory, restores social behaviors, and increases synaptic complexity in late-onset Alzheimer’s disease .
loading...
    loading...